AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+7.02%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$5.38B
AUM Growth
+$5.38B
(+6.7%)
Cap. Flow
+$11.7M
Cap. Flow
% of AUM
0.22%
Top 10 Holdings %
Top 10 Hldgs %
92.84%
Holding
124
New
16
Increased
27
Reduced
16
Closed
13
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$25.4M |
| 2 |
Incyte
INCY
|
$9.47M |
| 3 |
argenx
ARGX
|
$9.2M |
| 4 |
AXDX
Accelerate Diagnostics
AXDX
|
$7.86M |
| 5 |
Denali Therapeutics
DNLI
|
$7.82M |
Top Sells
| 1 |
Nektar Therapeutics
NKTR
|
$50.8M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$18.6M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$12.4M |
| 4 |
Neurocrine Biosciences
NBIX
|
$11.6M |
| 5 |
RXDX
Ignyta, Inc.
RXDX
|
$11.1M |
Sector Composition
| 1 | Consumer Staples | 53.33% |
| 2 | Consumer Discretionary | 24.25% |
| 3 | Healthcare | 21.69% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BUFF
1
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $2.87B | 43.26% | 87,460,875 | – | – |
|
|
WW
2
DELISTED
WW International
WW
| $1.3B | 19.67% | 29,443,300 | – | – |
|
3
Lexicon Pharmaceuticals
LXRX
$400M
| $576M | 8.68% | 58,274,650 +756,673 | +1% | +$7.48M |
|
|
4
Alnylam Pharmaceuticals
ALNY
$58.5B
| $57.2M | 0.86% | 450,000 +200,000 | +80% | +$25.4M |
|
|
5
Incyte
INCY
$16.5B
| $47.4M | 0.71% | 500,000 +100,000 | +25% | +$9.47M |
|
|
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
| $31.8M | 0.48% | 750,000 +50,000 | +7% | +$2.12M |
|
|
ONC
7
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $29.3M | 0.44% | 300,000 +75,000 | +33% | +$7.33M |
|
8
Agios Pharmaceuticals
AGIO
$2.19B
| $28.6M | 0.43% | 500,000 +50,000 | +11% | +$2.86M |
|
|
BLUE
9
DELISTED
bluebird bio
BLUE
| $26.7M | 0.4% | 150,000 +15,000 | +11% | +$2.67M |
|
|
10
Nektar Therapeutics
NKTR
$568M
| $23.9M | 0.36% | 400,000 -850,000 | -68% | -$50.8M |
|
|
11
Neurocrine Biosciences
NBIX
$13.8B
| $19.4M | 0.29% | 250,000 -150,000 | -38% | -$11.6M |
|
|
ARRY
12
DELISTED
Array Biopharma Inc
ARRY
| $19.2M | 0.29% | 1,500,000 | – | – |
|
13
Atara Biotherapeutics
ATRA
$84.6M
| $18.1M | 0.27% | 1,000,000 +400,000 | +67% | +$7.24M |
|
|
AVXS
14
DELISTED
AveXis, Inc. Common Stock
AVXS
| $16.6M | 0.25% | 150,000 +30,000 | +25% | +$3.32M |
|
15
AnaptysBio
ANAB
$569M
| $15.1M | 0.23% | 150,000 | – | – |
|
16
Amicus Therapeutics
FOLD
$2.34B
| $14.4M | 0.22% | 1,000,000 +300,000 | +43% | +$4.32M |
|
|
GBT
17
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $13.8M | 0.21% | 350,000 +50,000 | +17% | +$1.97M |
|
|
AXDX
18
DELISTED
Accelerate Diagnostics
AXDX
| $13.1M | 0.2% | 500,000 +300,000 | +150% | +$7.86M |
|
|
RDUS
19
DELISTED
Radius Health, Inc.
RDUS
| $12.7M | 0.19% | 400,000 +150,000 | +60% | +$4.77M |
|
|
20
argenx
ARGX
$43.6B
| $12.6M | 0.19% | 200,000 +145,663 | +268% | +$9.2M |
|
|
SAGE
21
DELISTED
Sage Therapeutics
SAGE
| $12.4M | 0.19% | 75,000 -75,000 | -50% | -$12.4M |
|
22
Regenxbio
RGNX
$451M
| $8.31M | 0.13% | 250,000 +90,000 | +56% | +$2.99M |
|
|
TSRO
23
DELISTED
TESARO, Inc.
TSRO
| $8.29M | 0.13% | 100,000 +25,000 | +33% | +$2.07M |
|
|
AGEN
24
Agenus
AGEN
$133M
| $8.15M | 0.12% | 2,500,255 +255 | +0% | +$831 |
|
|
25
Denali Therapeutics
DNLI
$2.23B
| $7.82M | 0.12% | +500,000 | New | +$7.82M |
|